The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Michael G. Wyllie

Urodoc Ltd

Maryland

Ridgeway Road

Herne

UK

[email]@urodoc.co.uk

Name/email consistency: low

 
 
 
 
 
 
 

Affiliations

  • Urodoc Ltd, Maryland, Ridgeway Road, Herne, UK. 2004 - 2007
  • Urodoc Ltd, Faversham, UK. 2006 - 2007
  • Urodoc, Herne Bay, UK. 2003 - 2006
  • URODOC Ltd, UK. 2002

References

  1. Clinical trials for aspiring dummies (and urologists). Wyllie, M.G. BJU Int. (2007) [Pubmed]
  2. Slow progress in prostate cancer. Wyllie, M.G. BJU Int. (2007) [Pubmed]
  3. Left to our own devices. Wyllie, M.G. BJU Int. (2006) [Pubmed]
  4. What's the point?. Wyllie, M.G. BJU Int. (2006) [Pubmed]
  5. Another year, another AUA. Wyllie, M.G. BJU Int. (2006) [Pubmed]
  6. Just hold on a minute (or should it be two?). Wyllie, M.G. BJU Int. (2006) [Pubmed]
  7. The urogynaecologist's perspective. Wyllie, M.G. BJU Int. (2006) [Pubmed]
  8. Just around the corner: effective therapy for Peyronie's disease?. Wyllie, M.G. BJU Int. (2006) [Pubmed]
  9. Have the wheels come off the Asian-Pacific revolution?. Wyllie, M.G. BJU Int. (2006) [Pubmed]
  10. The hunt for pink Viagra. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  11. Two for the price of one?. Wyllie, M. Br. J. Pharmacol. (2005) [Pubmed]
  12. An Asia-Pacific revolution?. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  13. Andropause on the move?. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  14. Back to the future for urological drug development?. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  15. Is urological drug discovery in the doldrums?. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  16. Evergreening: there's life in the old drug yet. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  17. Unseen forces at AUA 2005?. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  18. One drug fits all. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  19. Light at the end of the tunnel for interstitial cystitis?. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  20. Promise for prostatitis?. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  21. Urological flood or drought in 2006?. Wyllie, M.G. BJU Int. (2005) [Pubmed]
  22. Let's hope for more in 2004. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  23. Hormone-based approaches: altering the balance. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  24. Industry and conferences, a parasitic or symbiotic relationship?. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  25. Stress incontinence: help at hand. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  26. Urological research within the pharmaceutical industry: back to basics?. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  27. Fertility under control?. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  28. It's new and exciting--can it be AUA 2004?. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  29. The science (or art?) of new clinical trial designs. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  30. The final dose of clinical trial designs. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  31. The brain leads the way. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  32. Mind over matter: CNS-based approaches to urological diseases. Wyllie, M.G. BJU Int. (2004) [Pubmed]
  33. Gene therapy, urological disease and the pharmaceutical industry. Wyllie, M.G. BJU Int. (2003) [Pubmed]
  34. As we enter the new year, several new drugs will be launched globally. Wyllie, M.G. BJU Int. (2003) [Pubmed]
  35. The phosphodiesterase inhibitor 'war'. Wyllie, M.G. BJU Int. (2003) [Pubmed]
  36. The genesis of a phyto-pharmaceutical industry (Mark II). Wyllie, M.G. BJU Int. (2003) [Pubmed]
  37. ADAM and the andropause. Wyllie, M.G. BJU Int. (2003) [Pubmed]
  38. Uroselectivity: end of the road?. Wyllie, M.G. BJU Int. (2003) [Pubmed]
  39. Libido and desire: join the club?. Wyllie, M.G. BJU Int. (2003) [Pubmed]
  40. Pharmacokinetic fixes for pharmacodynamic deficits. Wyllie, M. BJU Int. (2003) [Pubmed]
  41. The Second International Consultation on Erectile Dysfunction: highlights from the pharmaceutical industry. Wyllie, M.G. BJU Int. (2003) [Pubmed]
  42. Indians to the rescue!. Wyllie, M.G. BJU Int. (2003) [Pubmed]
  43. Androgen-independent prostate cancer: a growth area?. Wyllie, M.G. BJU Int. (2003) [Pubmed]
  44. Female sexual dysfunction. Wyllie, M. Curr. Opin. Investig. Drugs (2002) [Pubmed]
 
WikiGenes - Universities